1.
Quann K, Lontos K, Sehgal A, Raptis A, Im A, Redner RL, Dorritie KA, Agha M, Hou J-Z, Farah R, Rossetti J, Normolle DP, Whiteside TL, Hsu Y-MS, Boyiadzis M. A phase II study of post-remission therapy with pembrolizumab in older patients with acute myeloid leukemia. Haematologica; https://doi.org/10.3324/haematol.2024.285313 [Early view].